cetugex
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2010 (NCT01222637)
Timeline
Indications
Mechanism of action
EGFR inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- cetugex
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02052960 | Phase 2 | Jan 1, 2014 | Glycotope GmbH, Humboldt University |
| NCT01222637 | Phase 1 | Aug 1, 2010 | Glycotope GmbH |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Glycotope GmbH | For profit | 2 | 2 | 2 | 2010 |
| Humboldt University | Academic/Hospital | 1 | 0 | 1 | 2014 |
2 organizations
Page 1 / 1